Regulatory & Legal

On Rare Disease Day, Polaryx Therapeutics advances a novel oral drug in a pivotal trial for four devastating pediatric disorders, offering a new strategy.

The global Edtech firm's prestigious accreditation signals a new era of accountability, forcing a reckoning on quality in the online tutoring market.

Antelope Enterprise Holdings just bought $1M in Bitcoin, launching its 'Genius Plan.' But with falling revenue, is this a bold new chapter or a risky bet?

Two college students are set to pitch their record-breaking material science innovation on ABC's Shark Tank, starting with a product you use every day.

A new technology bypasses device makers to give networks unprecedented control of location data, promising to power a new economy of 'Physical AI'.

Childhelp co-founder Sara O'Meara receives a lifetime achievement award, highlighting a new partnership and the ongoing fight to protect vulnerable children.

Despite a dip in annual profits, Boralex commissions major UK and Canadian projects, showcasing financial resilience and commitment to its 2030 growth plan.

A key European panel recommends Dupixent for children with chronic hives, offering a potential first-of-its-kind targeted therapy for a difficult condition.

A new lawsuit from a rival CEO puts Jura Energy's Pakistani assets in the crosshairs, escalating a feud rooted in a multi-million dollar arbitration.

At a UN event, Beijing launched a book on its governance model and promoted its Global Governance Initiative, signaling a push to reshape international order.

Graphite One's new tradable warrants aim to fund a vital domestic graphite project, but investors face a long road from financial maneuver to production.

After a challenging year, InTest Corp. posts a strong Q4 rebound, driven by growth in non-semi markets. A robust backlog signals a promising 2026.

The biopharma firm beats 2025 guidance on strong specialty and generic sales, forecasting another year of growth fueled by new product launches.

A landmark partnership digitizes the Royal Archives, offering unprecedented online access to the inner workings of the British Empire for the first time.

The Nordic tech firm shows signs of operational recovery and a promising AI strategy, but a mountain of debt and negative equity casts a long shadow.

Japan's Ministry of Defense partners with TIER IV to deploy autonomous ground vehicles, aiming to solve manpower shortages and modernize national security.

Decades of disinvestment have left rural Maryland behind. Now, a new initiative aims to unlock billions by empowering local leaders with powerful financial tools.

One in 10 Canadians has kidney disease, often with no symptoms. Experts urge immediate action as this silent crisis strains lives and our healthcare system.

Neurizon Therapeutics has started dosing its promising ALS drug, NUZ-001, in the groundbreaking HEALEY Platform Trial, a pivotal step for patients.

After a strategic pivot to focus purely on cell and gene therapy, BioLife reports strong revenue growth and a profitable quarter, eyeing further gains in 2026.